Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia
Allison Weaver, Samuel M. Rubinstein, Robert F. Cornell
Abstract
Hyperviscosity syndrome is a serious complication associated with high levels of paraproteins in patients with hematological malignancies. Therapeutic advances in disease control may reduce the incidence of hyperviscosity syndrome; however, management of acute cases requires an understanding of key symptoms and prompt treatment to mitigate serious consequences.
Topics & Concepts
HyperviscosityParaproteinsHyperviscosity syndromeMedicineMacroglobulinemiaWaldenstrom macroglobulinemiaComplicationIncidence (geometry)Intensive care medicineDiseaseMultiple myelomaInternal medicineImmunologyLymphomaBlood viscosityAntibodyMonoclonalPhysicsMonoclonal antibodyOpticsChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentCutaneous lymphoproliferative disorders research